SERPINB2 and Obesity: It is now well established that obesity is characterised by chronic inflammation (Greenberg and Obin, 2006; Park et al, 2010), with associated increases of CRP, interleukin-6 (IL-6) and plasminogen activator inhibitor (Dandona et al, 2004).